Rockwell Medical Inc (RMTI)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $27.92M
Last updated: Nov 17, 2026 at 11:05 AM ET
Rockwell Medical Inc (RMTI) Stock Forecast
Analysts expect Rockwell Medical (RMTI) to earn -$1.01 per share in the fiscal year ending Dec 31, 2026, on revenue of $72.78M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.21.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 8.0%.
- Fiscal year ending Dec 31, 2026
- -$1.01
- EPS consensus, revenue $72.78M
- Fiscal year ending Dec 31, 2027
- -$0.21
- EPS consensus, revenue $78.62M
- Next report
- Mar 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.01 | -$1.12 to -$0.90 | 2 | $72.78M | $72.19M to $73.37M | 2 |
| Dec 31, 2027 | -$0.21 | -$0.77 to $0.36 | 2 | $78.62M | $77.04M to $80.20M | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.07 | -$0.07 to -$0.07 | 4 | $19.39M | $18.50M to $20.09M | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.90.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.01 | -$1.12 | -$0.88 | -$0.88 | -$0.90 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.21 | -$0.17 | -$0.09 | -$0.09 | -$0.05 | N/A |
Frequently Asked Questions About RMTI
What is the RMTI stock forecast?
Consensus analyst estimates put Rockwell Medical's EPS at -$1.01 for the fiscal year ending Dec 31, 2026, on revenue of $72.78M.
What EPS do analysts expect from RMTI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.01, with estimates from -$1.12 to -$0.90 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.21, with estimates from -$0.77 to $0.36 from 2 analysts.
What revenue do analysts expect from Rockwell Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $72.78M, with estimates from $72.19M to $73.37M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $78.62M, with estimates from $77.04M to $80.20M.
How many analysts cover RMTI?
2 analysts estimate EPS for Rockwell Medical for the fiscal year ending Dec 31, 2026.
RMTI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts